ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug HLX316 enters first human tests for tough cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called HLX316 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if it shrinks tumors, especially in ovarian and related cancers. About 41 pa…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called HLX97 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 138 adults with certain breast…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New drug HLX48 enters first human trial for advanced cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called HLX48 in 72 adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. HLX48 is designed to target two cancer-related proteins, …
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Smart cancer trial aims to match treatments to patients' immune fingerprints
Knowledge-focused Not yet recruitingThis study tests a new way to pick the right immunotherapy for people with advanced cancers. Instead of relying only on the cancer's location, it uses a rapid blood and tumor test to create a detailed immune profile for each patient. The goal is to see if this personalized approa…
Matched conditions: ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC